This topic contains a solution. Click here to go to the answer

Author Question: A patient with cancer is receiving pegfilgrastim (Neulasta). The patient reports bone pain, which ... (Read 32 times)

crazycityslicker

  • Hero Member
  • *****
  • Posts: 537
A patient with cancer is receiving pegfilgrastim (Neulasta). The patient reports bone pain, which the nurse recognizes as
 
  a. a sign of cancer metastasis.
  b. an indication of expansion of bone marrow.
  c. caused by osteomyelitis.
  d. worsening neutropenia.

Question 2

A patient has been receiving an erythropoietin-stimulating agent (ESA) for 8 weeks. The nurse reviews the patient's chart and notes no increase in hemoglobin levels from 8 g/dL on week 3 of therapy. The nurse will request an order for
 
  a. a complete blood count and serum iron levels.
  b. an increased dose of the erythropoietin-stimulating agent.
  c. more frequent dosing of the ESA.
  d. packed red blood cell infusions.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nathang24

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

ANS: B
Bone pain is common with these drugs and is caused by expansion of the bone marrow. It does not indicate metastasis. The bone pain is not due to osteomyelitis or neutropenia.

Answer to Question 2

ANS: A
If there is no response, ESAs should be discontinued after 8 weeks of therapy. If a patient does not respond, iron deficiency or underlying hematologic disease should be considered and evaluated.




crazycityslicker

  • Member
  • Posts: 537
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


duy1981999

  • Member
  • Posts: 341
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

For a complete list of videos, visit our video library